Mettler ToledoMTDEarnings & Financial Report
Mettler Toledo, stylized in all caps, is a multinational supplier of precision instruments and services. The company focuses on laboratory, industrial, product inspection, and food retailing applications. Its products are used in research, quality control, and manufacturing processes in life sciences, food, chemical, and many other industries.
营收
$942.5M
毛利润
$559.5M
营业利润
N/A
净利润
$201.6M
毛利率
59.4%
营业利润率
N/A
净利率
21.4%
同比增长
-4.4%
EPS
$9.21
资金流向
Mettler Toledo Q3 2023 Financial Summary
Mettler Toledo reported revenue of $942.5M for Q3 2023, with a net profit of $201.6M (21.4% margin). Cost of goods sold was $382.9M, operating expenses totaled N/A.
Key Financial Metrics
| Total Revenue | $942.5M |
|---|---|
| Net Profit | $201.6M |
| Gross Margin | 59.4% |
| Operating Margin | N/A |
| Report Period | Q3 2023 |
Mettler Toledo Annual Revenue by Year
Mettler Toledo annual revenue history includes year-by-year totals (for example, 2025 revenue was $4.0B).
| Year | Annual Revenue |
|---|---|
| 2025 | $4.0B |
| 2024 | $3.9B |
| 2023 | $3.8B |
| 2022 | $3.9B |
利润表
| Q1 2024 | Q2 2024 | Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | Q4 2025 | |
|---|---|---|---|---|---|---|---|---|
| 营收 | $925.9M | $946.8M | $954.5M | $1.05B | $883.7M | $983.2M | $1.03B | $1.13B |
| 同比增长 | -0.3% | -3.6% | 1.3% | 11.8% | -4.6% | 3.9% | 7.9% | 8.1% |
资产负债表
| Q1 2024 | Q2 2024 | Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | Q4 2025 | |
|---|---|---|---|---|---|---|---|---|
| 总资产 | $3.28B | $3.25B | $3.32B | $3.24B | $3.23B | $3.40B | $3.52B | $3.71B |
| 总负债 | $3.44B | $3.40B | $3.47B | $3.37B | $3.42B | $3.66B | $3.77B | $3.74B |
| 股东权益 | $-158.7M | $-152.8M | $-154.4M | $-126.9M | $-182.0M | $-258.8M | $-249.2M | $-23.6M |
现金流量表
| Q1 2024 | Q2 2024 | Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | Q4 2025 | |
|---|---|---|---|---|---|---|---|---|
| 经营性现金流 | $190.0M | $257.5M | $254.7M | $266.2M | $194.4M | $236.4M | $299.4M | $225.6M |
Other Health Care Companies
A
Agilent Technologies
营收
$1.9B
净利润
$434.0M
TECH
Bio-Techne
营收
$295.9M
净利润
$38.0M
CRL
Charles River Laboratories
营收
$994.2M
净利润
$-276.6M
DHR
Danaher Corporation
营收
$6.1B
净利润
$908.0M
IQV
IQVIA
营收
$4.4B
净利润
$514.0M
TMO
Thermo Fisher Scientific
营收
$11.1B
净利润
$1.6B
ABT
Abbott Laboratories
营收
$11.4B
净利润
$1.6B
ABBV
AbbVie
营收
$15.8B
净利润
$186.0M
ALGN
Align Technology
营收
$995.7M
净利润
$56.8M
AMGN
Amgen
营收
$9.9B
净利润
$1.3B